Financial results at a glance

KEY FEATURES                
  year ended
30 June 2014

 

year ended
30 June 2013
year ended
30 June 2012
  % change
2014/2013
% change
2013/2012
 
Revenue (R millions) 1 958 260   1 770 330 1 448 261   10.6% 22.2%  
Operating profit (R millions) 356 357   333 657 259 301   6.8% 28.7%  
Headline earnings (R millions) 183 945   129 637 148 793   41.9% (12.9%)  
Cash generated from operations (R millions) 321 044   340 413 255 152   (5.7%) 33.4%  
                 
Normalised headline earnings per share (cents)                
- Attributable to ordinary shares (cents) 50.63   62.95 51.69   (2.8%) 21.8%  
- Diluted earnings per share (cents) 50.63   37.42 30.63   63.5% 22.2%  
                 
Statutory earnings per share (cents)                
Basic 40.00   60.75 61.55   (34.2%) (1.3%)  
Diluted 40.00   36.11 52.31   10.8% (31.0%)  
                 
Statutory headline earnings per share (cents)                
Basic 47.83   48.15 55.67   3.1% (13.5%)  
Diluted 47.83   28.62 47.58   73.5% (39.8%)  
                 
Dividends paid per ordinary share (cents) 18.00   15.00 10.50        
                 
Share price as at 30 June (Rand) 4.45   3.90 3.05        
                 
Group membership 1 417 970   1 405 233 1 360 796        
Open schemes 368 411   368 832 348 517        
Closed schemes 112 990   119 854 118 246        
GEMS 683 712   673 966 640 807        
SADEC and other 252 857   242 581 253 226        
                 

HEADLINE EARNINGS PER SHARE (COMPOUNDED 5 YEARS) Headlines earning

THREE-YEAR CONSOLIDATED PROFIT STATEMENT

  year ended
30 June 2014
R’000
  year ended
30 June 2013
R’000
year ended
30 June 2012
R’000
  % change
2014/2013
% change
2013/2012
 
Revenue 1 958 260   1 770 330 1 448 261   10.6% 22.2%  
Operating costs (1 601 903)   (1 436 673) (1 188 960)        
Operating profit 356 357   333 657 259 301   6.8% 28.7%  
Other income 2   2 307 14 894        
Net finance income 17 699   8 168 3 371        
Foreign exchange benefit 83   1 900        
Share of associate (losses)/profits – Jasco 2 805   (30 030) 5 988        
Share of associate profits – Healthcare 1 536   8 553 8 854        
Profit before impairment and amortisation 378 483   324 555 292 408   16.6% 11.0%  
Reversal of impairment 3 720   7 253 13 162        
Fair value gain of investment   5 252 1 175        
Impairment of intangible asset (40 620)          
Share-based payment expense (10 765)   (39 868) (9 357)        
Profit on sale of investment   51 014        
Depreciation (40 475)   (37 251) (38 128)        
Amortisation of intangible assets (43 907)   (40 098) (36 356)        
Profit before income tax 246 436   270 857 222 904   (9.0%) 21.5%  
 

NORMALISED INCOME STATEMENT

  year ended
30 June 2014
R’000
  year ended
30 June 2013
R’000
year ended
30 June 2012
R’000
  % change
2014/2013
% change
2013/2012
 
Profit before impairment and amortisation 378 483   324 555 292 408   16.6% 11.0%  
Impairment of intangible asset (Note 1) 40 620          
Share of associate losses - Jasco (Note 2)   30 030        
Cash profits from core operations 419 103   354 585 292 408        
Depreciation (40 475)   (37 251) (38 128)        
Amortisation of intangible assets (43 907)   (40 098) (36 356)        
Share-based payment expense (10 765)   (39 868) (9 357)        
Net profit before tax from core operations 323 955   237 368 208 567   36.5% 13.8%  
Normalised effective tax charge @28% 90 707   66 463 58 399        
Net profit after tax from core operations 233 248   170 905 150 168        
Note 1: The impairment of intangible asset for the 2014 year represents a once-off impairment which is not in the normal course of business.
Note 2: The significant losses from Jasco for the 2013 year represents a once-off investment impairment which is not in the normal course of business.
Note: The summarised report on pages 26 to 29 is extracted from audited information but is not itself audited. The annual financial statements were audited by PricewaterhouseCoopers Inc. and SizweNtsalubaGobodo Inc. who expressed an unmodified opinion thereon. The audited annual financial statements and the auditors report thereon are available for inspection on pages 110 to 188 of the integrated annual report. The Directors take full responsibility for the preparation of the summarised report and that the financial information has been correctly extracted from the underlying annual financial statements.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

  year ended
30 June 2014
R’000
  year ended
30 June 2013
R’000
year ended
30 June 2012
R’000
  % change
2014/2013
% change
2013/2012
 
Cash generated from operations 321 044   340 413 255 152        
Net finance income 17 699   8 168 3 371        
Distribution to shareholders (70 178)   (33 196) (28 268)        
Tax and other payments (112 301)   (88 305) (114 050)        
Net cash inflow from operating activities 156 264   227 080 116 205        
Net cash outflow from investing activities (62 940)   (114 459) (55 321)        
Net cash inflow from financing activities (64 169)   3 780 8 315        
Effect of foreign exchange benefit 83   1 900        
Net increase in cash and cash equivalents 29 238   118 301 69 199        
Cash and cash equivalents at beginning of the period 360 211   241 910 172 711        
Cash and cash equivalents at end of the period 389 449   360 211 241 910   8.1% 48.9%  

As capital expenditure is fairly low in this industry a high value is attached the cash generating abilities of the Group which is clearly above market averages compared to other industries.

EARNINGS ATTRIBUTABLE TO EQUITY HOLDERS

  year ended
30 June 2014
R’000
  year ended
30 June 2013
R’000
year ended
30 June 2012
R’000
  % change
2014/2013
% change
2013/2012
 
Number of ordinary shares in issue 467 855 101   270 010 639 268 231 817        
Number of preference shares in issue   16 638 000 16 638 000        
Weighted average number of ordinary shares 384 574 258   269 256 170 267 276 657        
Weighted average number of shares for diluted EPS which include shares on conversion of preference shares share-based awards and second tranche shares issued 384 574 258   452 953 162 332 384 302        
Basic earnings 153 823   163 570 164 506        
Adjusted by: 30 122   (33 933) (15 713)        
 – Impairment of intangible asset 40 620          
 – Adjustment of impairments recognised by associate   30 030        
 – Fair value gain on investment   (5 252) (1 175)        
 – Reversal of impairment (3 720)   (7 253) (13 162)        
 – Loss/(profit) on disposal of assets 235   (440) (566)        
 – Loss/(profit) on disposal of assets   (51 014)        
 – Fair value adjustments (other)   (4) (810)        
Total tax effects of adjustments (4 906)          
Total NCI effects of adjustments (2 107)          
Headline earnings 183 945   129 637 148 793   41.9% (12.9%)  
Earnings per share (cents)                
  – Attributable to ordinary shares (cents) 40.00   60.75 61.55   (34.2%) (1.3%)  
  – Diluted earnings per share (cents) 40.00   36.11 52.31   10.8% (31.0%)  
Headline earnings per share (cents)                
  – Attributable to ordinary shares (cents) 47.83   48.15 55.67   3.1% (13.5%)  
  – Diluted earnings per share (cents) 47.83   28.62 47.58   73.5% (39.8%)  
Cash earnings per share                
  – Attributable to ordinary shares (cents) 83.48   126.43 95.48   (34.0%) 32.4%  
  – Diluted earnings per share (cents) 83.48   75.15 76.77   11.1% (2.1%)  

DETERMINATION OF NORMALISED EARNINGS PER SHARE

  2014   2013 2012   Growth in
shares from
2013-2014
Basic earnings 153 823   163 570 164 506    
Share-based payment expense 10 765   39 868 9 357    
Normalised tax adjustment in 2012 (at 28%)   (20 000)    
Normalised basic earnings 164 588   203 438 153 863    
Adjusted by:            
  – Impairment of intangible assets 40 620      
  – Adjustment of impairments recognised by   30 030    
  – Fair value gain on investment   (5 252) (1 175)    
  – Reversal of impairment (3 720)   (7 253) (13 162)    
  – Loss/(profit) on disposal of assets 235   (440) (566)    
  – Loss/(profit) on disposal of assets   (51 014)    
  – Fair value adjustments (other)   (4) (810)    
  – Total tax effects of adjustments (4 906)      
  – Total NCI effects of adjustments (2 107)      
Normalised headline earnings 194 710   169 505 138 150    
Growth per annum 15%   23%      
Weighted average number of ordinary shares 384 574 258   269 256 170 267 276 657   43%
Weighted average number of shares for diluted EPS which include shares on conversion of preference shares share-based awards and second 384 574 258   452 953 162 450 978 885   (15%)

NORMALISED HEADLINE EARNINGS PER SHARE (CENTS)

  2014   2013 2012  
Attributable to ordinary shares (cents) 72.31   62.95 51.69  
– Actual 50.63        
– 43% dilutionary effect of additional shares 21.68        
Growth per annum 15%   22%    
Diluted earnings per share (cents) 42.99   37.42 30.63  
– Actual 50.63        
– 15% dilutionary effect of shares due to weighted periods used (7.64)        
Growth per annum 15%   22%    
 
 
USEFUL LINKS

View our corporate website

 
E-BOOK

Use this link to view our Integrated Report as an E-Book

 
DOWNLOADS

This report is available to download as a full document and in sections.